Management of HER2-Altered Non-Small Cell Lung Cancer
Release Date:
Dr Bob Li from Memorial Sloan Kettering Cancer Center in New York City discusses the current and future roles of targeted therapy for HER2-altered non-small cell lung cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayHER2AlteredNSCLC22).
Management of HER2-Altered Non-Small Cell Lung Cancer